D Lambrechts, E Storkebaum, M Morimoto, J … - Nature genetics, 2003 - nature.com 1 The Center for Transgene Technology and Gene Therapy, Flanders Interuniversity
Institute for Biotechnology and Departments of Neurology and Internal Medicine,
University Hospital Gasthuisberg, KU Leuven, Leuven, B-3000, Belgium. Cited by 377 - Related articles - BL Direct - All 8 versions
BF Schrijvers, A Flyvbjerg, AS De Vriese - Kidney international, 2004 - nature.com Received 24 April 2003; Revised 7 August 2003; Re-revised 25 September 2003;
Accepted 3 December 2003. ... The role of vascular endothelial growth factor
(VEGF) in renal pathophysiology. Vascular endothelial growth factor (VEGF) ... Cited by 143 - Related articles - BL Direct - All 7 versions
I Stalmans, D Lambrechts, F De Smet, S … - Nature medicine, 2003 - allserv.rug.ac.be Numerous molecules, including the vascular endothelial growth factor (VEGF),
have been implicated in the assembly of a primi- tive vascular network1. It is
unclear, however, which molecules control the subsequent remodeling into a ... Cited by 133 - Related articles - View as HTML - BL Direct - All 7 versions
- ►aacrjournals.org A Stevens, J Soden, PE Brenchley, S Ralph, … - Cancer research, 2003 - AACR The human vascular endothelial growth factor (VEGF) gene is unusually
polymorphic,and there is evidence for inheritance of conserved haplotypes.One
haplotype, carrying polymorphisms at -460/+405, is associated with enhanced ... Cited by 139 - Related articles - BL Direct - All 4 versions
P Krippl, U Langsenlehner, W Renner, B … - International Journal of Cancer, 2003 - interscience.wiley.com A common 936 C/T polymorphism in the gene for the vascular endothelial growth
factor (VEGF) has been associated with VEGF plasma levels. In our case-control
study, we investigated the role of this polymorphism for breast cancer ... Cited by 129 - Related articles - BL Direct - All 3 versions
RM Bremnes, C Camps, R Sirera - Lung Cancer, 2006 - Elsevier Due to a dismal prognosis of advanced lung cancer, novel screening tools and
more effective treatments are clearly needed. Lately, an increasing number of
tumour-released angiogenic cytokines which affect vessel formation, tumour ... Cited by 95 - Related articles - All 14 versions
- ►diabetesjournals.org D Ray, M Mishra, S Ralph, I Read, R Davies, … - Diabetes, 2004 - Am Diabetes Assoc Diabetic retinopathy and nephropathy cause significant morbidity in patients
with diabetes. Vascular endothelial growth factor (VEGF) is a potent angiogenic
and vascular permeability factor and is implicated in both of these ... Cited by 81 - Related articles - BL Direct - All 5 versions
- ►aacrjournals.org Q Jin, K Hemminki, K Enquist, P Lenner, E … - Clinical Cancer Research, 2005 - AACR Results: None of the polymorphisms or any haplotype was significantly associated
with either familial or unselected breast cancers. Our study suggests that the
+936C/T polymorphism is unlikely to be associated with breast cancer. We ... Cited by 73 - Related articles - All 6 versions
- ►aacrjournals.org H Lu, XO Shu, Y Cui, N Kataoka, W Wen, Q … - Cancer research, 2005 - AACR The vascular endothelial growth factor (VEGF) is an important regulator of
angiogenesis and vascular permeability. VEGF overexpression has been associated
with advanced stage and poor survival of several cancers. We evaluated the ... Cited by 67 - Related articles - All 5 versions
SJ Lee, SY Lee, HS Jeon, SH Park, JS Jang, … - Cancer Epidemiology Biomarkers & Prevention, 2005 - AACR Angiogenesis is an essential process in the development, growth, and metastasis
of malignant tumors including lung cancer. DNA sequence variations in the
vascular endothelial growth factor (VEGF) gene may lead to altered VEGF ... Cited by 64 - Related articles - All 6 versions
